SCHEMBL4686595

SCHEMBL4686595

COC(=O)C(OC)C(=O)c1csc(N)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.50
ALDH1A1 P00352 7/20 0.50
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
SMN1; SMN2 Q16637 3/20 0.37
LMNA P02545 2/20 0.37
KDM4E B2RXH2 3/20 0.35
TDP1 Q9NUW8 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
HTT P42858 2/20 0.35
PKM P14618 1/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 2/20 0.35
GABRA5 P31644 1/20 0.35
GABRB2 P47870 1/20 0.35
MAPK1 P28482 1/20 0.34
NOS1 P29475 1/20 0.34
POLB P06746 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL230453 0.75 MAPT (0.65) MAPTALDH1A1MEN1KMT2ANPC1
SCHEMBL4687408 0.75 ALDH1A1 (0.51) MAPTALDH1A1MEN1KMT2ANPC1
Bromide SCHEMBL5929889 0.74 MAPT (0.63) MAPTALDH1A1MEN1KMT2ANPC1
SCHEMBL4686285 0.72 ABCB1 (0.32)
SCHEMBL28518579 0.72 MAPT (0.53) MAPTALDH1A1MEN1KMT2ANPC1
SCHEMBL21044317 0.72 ALDH1A1 (0.42) MAPTALDH1A1MEN1KMT2ANPC1
SCHEMBL19914329 0.71 NPC1 (0.51) MAPTALDH1A1MEN1KMT2ANPC1
SCHEMBL27703549 0.71 ALDH1A1 (0.50) MAPTALDH1A1MEN1KMT2ANPC1
SCHEMBL27631522 0.70 MAPT (0.50) MAPTALDH1A1MEN1KMT2ANPC1
SCHEMBL27784803 0.70 ALDH1A1 (0.49) MAPTALDH1A1MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7427635-B2 Substituted hydantoins HOFFMANN-LA ROCHE INC. (US) 2008-09-23 US disclosed
EP-1781649-B1 SUBSTITUTED HYDANTOINS HOFFMANN LA ROCHE (CH) 2008-08-13 EP disclosed
EP-1781649-A2 SUBSTITUTED HYDANTOINS F. Hoffmann-Roche AG (CH) 2007-05-09 EP disclosed
US-20060041146-A1 Substituted hydantoins HOFFMANN-LA ROCHE AG 2006-02-23 US disclosed
WO-2006018188-A2 SUBSTITUTED HYDANTOINS F. HOFFMANN-LA ROCHE AG (CH) 2006-02-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060041146-A1 Substituted hydantoins HNMT, MAPK6, KYNU MAPT 2100/4885ALDH1A1 552/4885MEN1 460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.